286 related articles for article (PubMed ID: 12756825)
1. [How to establish GCP-units in Denmark?].
Krogsgaard K; Andreasen PB
Ugeskr Laeger; 2003 Apr; 165(16):1665-7. PubMed ID: 12756825
[TBL] [Abstract][Full Text] [Related]
2. [Public GCP unit--experiences from the Aarhus University Hospital].
Jørgensen A; Rønnow IL; Nexø E
Ugeskr Laeger; 2003 Apr; 165(16):1667-9. PubMed ID: 12756826
[TBL] [Abstract][Full Text] [Related]
3. [The GCP directive--consequences for clinical drug research].
Gluud CN
Ugeskr Laeger; 2003 Apr; 165(16):1662-4. PubMed ID: 12756824
[TBL] [Abstract][Full Text] [Related]
4. [ICH-GCP Guideline: quality assurance of clinical trials. Status and perspectives].
Englev E; Petersen KP
Ugeskr Laeger; 2003 Apr; 165(16):1659-62. PubMed ID: 12756823
[TBL] [Abstract][Full Text] [Related]
5. [The inspection by the Danish Medical Products Agency of drug clinical trials].
Jacobsen E; Stilbo I
Ugeskr Laeger; 2003 Apr; 165(16):1656-8. PubMed ID: 12756822
[TBL] [Abstract][Full Text] [Related]
6. [The roles and responsibilities of the pharmaceutical industry].
Dejgaard A; Thomsen MK
Ugeskr Laeger; 2003 Apr; 165(16):1676-9. PubMed ID: 12756829
[TBL] [Abstract][Full Text] [Related]
7. Status of the GCP guidelines in Europe.
Geussenhainer S
Methods Find Exp Clin Pharmacol; 1993 May; 15(4):223-8. PubMed ID: 8361259
[TBL] [Abstract][Full Text] [Related]
8. [The role of the Danish Medical Products Agency in clinical trials].
Simonsen AC
Ugeskr Laeger; 2003 Apr; 165(16):1653-6. PubMed ID: 12756821
[TBL] [Abstract][Full Text] [Related]
9. Establishing pan-European clinical trials: regulatory compliance and other practical considerations.
Grienenberger A
J Biolaw Bus; 2004; 7(4):58-63. PubMed ID: 15675097
[TBL] [Abstract][Full Text] [Related]
10. [Development of anti-cancer drugs under new renewed GCP--from the viewpoint of drug development company developer].
Ueno T; Kobayashi T; Inoue K; Yanagi Y; Yamada Y
Gan To Kagaku Ryoho; 1998 Apr; 25(5):663-70. PubMed ID: 9571963
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and quality in clinical trials. Requirements to the investigator site. European Economic Community.
Friederichs E; Spitzer SG; Bach R
Arzneimittelforschung; 1994 Feb; 44(2):182-4. PubMed ID: 8147953
[TBL] [Abstract][Full Text] [Related]
12. Stem cell transplantation in children: how to design a new study.
Corbacioglu S;
Bone Marrow Transplant; 2008 Jun; 41 Suppl 2():S30-4. PubMed ID: 18545241
[TBL] [Abstract][Full Text] [Related]
13. European Union clinical trials directive.
Bull Med Ethics; 2001 Jul; (169):13-24. PubMed ID: 11878337
[No Abstract] [Full Text] [Related]
14. [The scientific committee system].
Kamper-Jørgensen F
Ugeskr Laeger; 2003 Apr; 165(16):1680-2. PubMed ID: 12756830
[TBL] [Abstract][Full Text] [Related]
15. [Attitude of patient associations to clinical trials of new drugs].
Tybkjaer HW; Witte L; Johannessen MB
Ugeskr Laeger; 2003 Apr; 165(16):1688-90. PubMed ID: 12756833
[TBL] [Abstract][Full Text] [Related]
16. GCP data quality for early clinical development.
Rock EP; Molloy VJ; Humphrey JS
Clin Cancer Res; 2010 Mar; 16(6):1756-63. PubMed ID: 20215550
[TBL] [Abstract][Full Text] [Related]
17. [Experience as a model hospital for new good clinical practice (GCP) regulations].
Tanaka S
Gan To Kagaku Ryoho; 1998 Aug; 25(10):1467-73. PubMed ID: 9725036
[TBL] [Abstract][Full Text] [Related]
18. Experiences with GLP/GCP from the pharmaceutical industry's viewpoint.
Legler UF
Methods Find Exp Clin Pharmacol; 1993 May; 15(4):233-6. PubMed ID: 8361261
[TBL] [Abstract][Full Text] [Related]
19. [The GCP-unit at the Aaarhus University Hospital].
Jørgensen A; Fabricius S; Nexø E; Djurhuus JC; Rosenberg R; Hammer U; Christiansen JS
Ugeskr Laeger; 2000 Aug; 162(32):4288-90. PubMed ID: 10962954
[No Abstract] [Full Text] [Related]
20. [More stringent requirements concerning clinical research. The new EU rules come into effect on May 1].
Lafolie P
Lakartidningen; 2004 Mar; 101(10):917-20. PubMed ID: 15055055
[No Abstract] [Full Text] [Related]
[Next] [New Search]
